Warning letter
Arnold Professional Pharmacy: warning letter of Apr 7, 2017
FDA warning letter 521908 · Baltimore District Office
Key facts
| Reference number | 521908 |
|---|---|
| Company | Arnold Professional Pharmacy |
| Subject | Compounding Pharmacy/Adulterated Drug Products |
| Issue date | Apr 7, 2017 |
| Posted date | Apr 7, 2017 |
| Issuing office | Baltimore District Office |
| Product type | Drugs |
| CFR sections cited | 201.115, 200.10(b), 211.165(a), 210.1(b) |
| Inspection city | Arnold |
| Inspection ZIP | 21012-2704 |
| Inspection start date | May 2, 2016 |
| Letter on fda.gov | fda.gov |
At a glance
- 1–9 CFR sections cited
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: